Vous n'êtes pas connecté
QDEL announces the FDA's clearance for its VITROS syphilis assay, which boosts the company's infectious disease testing portfolio.
The FDA has delayed the approval of MDMA-assisted therapy for PTSD, citing the need for additional safety and efficacy data. Is this the end for...